Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study Accéder au pdf ► Watch the video on YouTube ► Pham TT Communications orales 39th Annual Meeting of the European Bone and Joint Infection Society 2021
